These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15812184)

  • 21. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.
    Kolykhalov AA; Agapov EV; Blight KJ; Mihalik K; Feinstone SM; Rice CM
    Science; 1997 Jul; 277(5325):570-4. PubMed ID: 9228008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction.
    Prieto M; Olaso V; Verdú C; Córdoba J; Gisbert C; Rayón M; Carrasco D; Berenguer M; Higón MD; Berenguer J
    Hepatology; 1995 Aug; 22(2):413-7. PubMed ID: 7635408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles.
    Bassett SE; Brasky KM; Lanford RE
    J Virol; 1998 Apr; 72(4):2589-99. PubMed ID: 9525575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypocomplementemia associated with hepatitis C viremia in sera from voluntary blood donors.
    Itoh K; Tanaka H; Shiga J; Hirakawa K; Akahane Y; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1994 Nov; 89(11):2019-24. PubMed ID: 7524311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection.
    Puig M; Major ME; Mihalik K; Feinstone SM
    Vaccine; 2004 Feb; 22(8):991-1000. PubMed ID: 15161076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples.
    Daniel HD; Grant PR; Garson JA; Tedder RS; Chandy GM; Abraham P
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):415-20. PubMed ID: 18486403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
    Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber PS; Marinos G; Levy MH; Kaldor JM; Dolan KA; Ffrench RA; Lloyd AR; Rawlinson WD;
    J Infect Dis; 2004 May; 189(10):1846-55. PubMed ID: 15122521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection of a chimpanzee with hepatitis C virus grown in cell culture.
    Shimizu YK; Igarashi H; Kiyohara T; Shapiro M; Wong DC; Purcell RH; Yoshikura H
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1383-6. PubMed ID: 9634078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.
    Shata MT; Tricoche N; Perkus M; Tom D; Brotman B; McCormack P; Pfahler W; Lee DH; Tobler LH; Busch M; Prince AM
    Virology; 2003 Sep; 314(2):601-16. PubMed ID: 14554088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool.
    Bukh J; Apgar CL; Engle R; Govindarajan S; Hegerich PA; Tellier R; Wong DC; Elkins R; Kew MC
    J Infect Dis; 1998 Oct; 178(4):1193-7. PubMed ID: 9806059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.
    Kato T; Choi Y; Elmowalid G; Sapp RK; Barth H; Furusaka A; Mishiro S; Wakita T; Krawczynski K; Liang TJ
    Hepatology; 2008 Sep; 48(3):732-40. PubMed ID: 18712792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early events in hepatitis C virus infection of chimpanzees.
    Shimizu YK; Weiner AJ; Rosenblatt J; Wong DC; Shapiro M; Popkin T; Houghton M; Alter HJ; Purcell RH
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6441-4. PubMed ID: 2117282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes.
    Busch MP; Murthy KK; Kleinman SH; Hirschkorn DF; Herring BL; Delwart EL; Racanelli V; Yoon JC; Rehermann B; Alter HJ
    Blood; 2012 Jun; 119(26):6326-34. PubMed ID: 22498743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus viremia in SCID-->BNX mouse chimera.
    Galun E; Burakova T; Ketzinel M; Lubin I; Shezen E; Kahana Y; Eid A; Ilan Y; Rivkind A; Pizov G
    J Infect Dis; 1995 Jul; 172(1):25-30. PubMed ID: 7797923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.
    Thimme R; Bukh J; Spangenberg HC; Wieland S; Pemberton J; Steiger C; Govindarajan S; Purcell RH; Chisari FV
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15661-8. PubMed ID: 12441397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature.
    Kamili S; Krawczynski K; McCaustland K; Li X; Alter MJ
    Infect Control Hosp Epidemiol; 2007 May; 28(5):519-24. PubMed ID: 17464909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of immune globulin on the prevention of experimental hepatitis C virus infection.
    Krawczynski K; Alter MJ; Tankersley DL; Beach M; Robertson BH; Lambert S; Kuo G; Spelbring JE; Meeks E; Sinha S; Carson DA
    J Infect Dis; 1996 Apr; 173(4):822-8. PubMed ID: 8603959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.
    Dahari H; Major M; Zhang X; Mihalik K; Rice CM; Perelson AS; Feinstone SM; Neumann AU
    Gastroenterology; 2005 Apr; 128(4):1056-66. PubMed ID: 15825086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of protective immunity against reinfection with hepatitis C virus.
    Farci P; Alter HJ; Govindarajan S; Wong DC; Engle R; Lesniewski RR; Mushahwar IK; Desai SM; Miller RH; Ogata N
    Science; 1992 Oct; 258(5079):135-40. PubMed ID: 1279801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.